Ahmed Mohamed Nader
Ahmed Mohamed Nader
Verified email at abbvie.com
TitleCited byYear
Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making
F Jibril, S Sharaby, A Mohamed, KJ Wilby
The Canadian journal of hospital pharmacy 68 (3), 238, 2015
712015
Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration
RF Eyler, AM Vilay, AM Nader, M Heung, M Pleva, KM Sowinski, ...
Antimicrobial agents and chemotherapy 58 (3), 1320-1326, 2014
302014
Impact of immunogenicity on pharmacokinetics, efficacy and safety of adalimumab in adult patients with moderate to severe chronic plaque psoriasis
NM Mostafa, AM Nader, P Noertersheuser, M Okun, WM Awni
Journal of the European Academy of Dermatology and Venereology 31 (3), 490-497, 2017
182017
Suitability of digoxin as a P‐glycoprotein probe: Implications of other transporters on sensitivity and specificity
AM Nader, DR Foster
The Journal of Clinical Pharmacology 54 (1), 3-13, 2014
172014
A semi‐mechanistic metabolism model of CYP3A substrates in pregnancy: predicting changes in midazolam and nifedipine pharmacokinetics
SK Quinney, AN Mohamed, MF Hebert, DM Haas, S Clark, JG Umans, ...
CPT: pharmacometrics & systems pharmacology 1 (9), 1-9, 2012
152012
Population pharmacokinetics of intravenous methotrexate in patients with hematological malignancies: utilization of routine clinical monitoring parameters
A Nader, N Zahran, A Alshammaa, H Altaweel, N Kassem, KJ Wilby
European journal of drug metabolism and pharmacokinetics 42 (2), 221-228, 2017
122017
Gentamicin pharmacokinetics and pharmacodynamics during short-daily hemodialysis
BS Decker, AN Mohamed, M Chambers, MA Kraus, SM Moe, ...
American journal of nephrology 36 (2), 144-150, 2012
102012
Population pharmacokinetics and immunogenicity of adalimumab in adult patients with moderate-to-severe hidradenitis suppurativa
A Nader, D Beck, P Noertersheuser, D Williams, N Mostafa
Clinical pharmacokinetics 56 (9), 1091-1102, 2017
82017
Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine
AM Nader, SK Quinney, HM Fadda, DR Foster
The AAPS Journal, 1-8, 2016
72016
Population pharmacokinetics of elagolix in healthy women and women with endometriosis
I Winzenborg, A Nader, AR Polepally, M Liu, J Degner, CE Klein, ...
Clinical pharmacokinetics 57 (10), 1295-1306, 2018
52018
Pharmacokinetic modeling and simulation of procainamide and N-acetylprocainamide in a patient receiving continuous renal replacement therapy: a novel approach to guide renal …
AN Mohamed, AM Abdelhady, D Spencer, KM Sowinski, JE Tisdale, ...
American Journal of Kidney Diseases 61 (6), 1046-1048, 2013
52013
Identification of HLA-DRB1 association to adalimumab immunogenicity
M Liu, J Degner, JW Davis, KB Idler, A Nader, NM Mostafa, JF Waring
PloS one 13 (4), e0195325, 2018
42018
Clinical pharmacology of elagolix: an oral gonadotropin-releasing hormone receptor antagonist for endometriosis
M Shebley, AR Polepally, A Nader, JW Ng, I Winzenborg, CE Klein, ...
Clinical pharmacokinetics, 1-13, 2019
12019
Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of …
A Nader, S Stodtmann, A Friedel, MEF Mohamed, AA Othman
The Journal of Clinical Pharmacology, 2019
12019
FRI0138 EXPOSURE-RESPONSE ANALYSES OF UPADACITINIB EFFICACY AND SAFETY IN RHEUMATOID ARTHRITIS–ANALYSES OF PHASE 2 AND 3 STUDIES
ME Mohamed, A Nader, I Winzenborg, E Doelger, P Noertersheuser, ...
Annals of the Rheumatic Diseases 78 (Suppl 2), 739-740, 2019
12019
A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patient.
AL Myers, JD Kawedia, A Nader, JR Westin, BR Shank
Journal of clinical pharmacy and therapeutics, 2019
12019
Combined Efficacy and Safety Modeling and Simulation Approach to Inform Drug Development Decisions for an Oral Gonadotropin-releasing Hormone (GnRH) Receptor Antagonist
A Nader, I Winzenborg, A Suleiman, A Polepally, J Ng, M Shebley, ...
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S4-S4, 2018
12018
Long‐term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasis
R Gniadecki, CL Leonardi, KB Gordon, Y Gu, Z Geng, A Nader, ...
Journal of the European Academy of Dermatology and Venereology 32 (8), 1297-1304, 2018
12018
COMPARTMENTAL PHARMACOKINETICS (PK) OF IMMEDIATE RELEASE NIFEDIPINE (NIF) IN PREGNANCY: VARIABILITY IN ABSORPTION.: PIII-109
A Nader, S Caritis, M Hebert, S Clark, D Flockhart, S Quinney
Clinical Pharmacology & Therapeutics 91, 2012
12012
Exposure‐Response Analyses of Upadacitinib Efficacy and Safety in Phase 2 and 3 Studies to Support Benefit‐Risk Assessment in Rheumatoid Arthritis
A Nader, MEF Mohamed, I Winzenborg, E Doelger, P Noertersheuser, ...
Clinical Pharmacology & Therapeutics, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20